1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus: new trials by email Literature Review of Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus trials Research Report on Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment Anifrolumab - Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus | Phase 3 | Recruiting | AstraZeneca | 1072 | 2026-08-31 | 2026-10-02 |
anifrolumab (1)
AstraZeneca (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1)